CD8A and glioblastoma: When looking at checkpoint receptor expression on T cells, we observed more expression of PD-1 and TIGIT in CD4 and CD8 T cells in GBM patients, but no increase in Tim3 expression in comparison to controls (Fig. 1H, I).